A biopharmaceutical company with a compound targeting the prevention restinosis, a disease characterized by the re-closing of areteries after balloon angioplasty.
« Back to Client Directory
© 2010 Ben Franklin Technology Partners of Southeastern Pennsylvania
Building 100 Innovation Center
|
4801 S Broad St, Suite 200
The Navy Yard
|
Philadelphia, PA 19112
|
Get Directions
Tel. 215.972.6700
|
Fax 215.972.5588
Like us on FacebookFollow us on LinkedINFollow us on TwitterDiscussion Groups
Designed & Developed by Altitude Marketing